August 13, 2026 11:49 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Netaji row: Suvendu Adhikari govt strips BJP MP Anant Maharaj of state honour | Sukhbir Badal attacked by Nihang Sikh with kirpan at Maharashtra gurdwara; assailant detained | ‘If you cannot do it, we will pass an order’: Supreme Court’s final warning to Centre on food labels | ‘Time to move on’: Bombay HC sends strong message in Vijay Mallya-bank dispute | Netaji row explodes in Bengal: Suvendu Adhikari orders police action over ‘derogatory’ posts | Kolkata's NRS Hospital nurse found dead in washroom during night shift | RG Kar rape-murder case takes fresh turn as ex-TMC MLA Nirmal Ghosh arrested over cremation probe | ‘Govt has nothing to hide’: Amit Shah says ‘ready for debate’ on NEET crackdown; Rahul Gandhi hits back, ‘not interested in lecture’ | Tata Sons leadership shock: N Chandrasekaran won’t seek reappointment as chairman after February 2027 | ISI-linked Pakistani national arrested in Bengal over 'espionage' targeting Army, BSF, Railways
Stock Market
Representational Photo: ChatGPT

Market update: Sensex tumbles 120 points, Nifty below 25,850 at closing bell

| @indiablooms | Dec 17, 2025, at 04:00 pm

Mumbai/IBNS: The Indian stock market ended Wednesday on a negative note, with BSE Sensex falling 120 points and NSE Nifty 50 closing below 25,850. Sensex settled at 84,559.65, while Nifty finished at 25,818.55.

Among sector movers, HDFC Bank, ICICI Bank, Asian Paints, and Titan were top losers, while shares of Maruti, TCS, Tata Steel, Reliance, and Bharti Airtel witnessed gains.

The Indian rupee, which opened at a fresh low, rebounded to settle at ₹90.38 against the US dollar, marking a 0.7% gain—the biggest single-day rise since October 15.

Meanwhile, dialysis service provider Nephrocare Health Services made a strong stock market debut, listing at a premium of about 7%. The shares debuted at ₹491.70 on the BSE (6.8% premium) and ₹490 on the NSE (6.52% premium), according to CNBC-TV18.

Nephrocare’s ₹871.05-crore initial public offering (IPO), open for subscription from December 10–12, was oversubscribed 13.96 times, highlighting strong investor demand.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.